Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

计划入组 14 人 · 首次发布于 2016 年 1 月 13 日

Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome

计划入组 7 人 · 首次发布于 2012 年 6 月 21 日

A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa

计划入组 28 人 · 首次发布于 2019 年 2 月 11 日

MPC-4505

Delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists(University of Arizona)

Aprepitant(Aponvie, Cinvanti, Emend)

C₂₃H₂₁F₇N₄O₃ · Rx

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Hoth Therapeutics Receives US Patent for HT-ALZ, a Novel Alzheimer's Treatment

European Regulators Recommend Approval for Novo Nordisk's Weekly Diabetes Combination Therapy Kyinsu

FDA Lifts Clinical Hold on Tradipitant, Clearing Path for First New Motion Sickness Treatment in 40 Years